Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial.

Opzelura (ruxolitinib cream) - Incyte

http://www.ncbi.nlm.nih.gov/pubmed/42748944

Alina Markova; Andrew Harris; Brian C Shaffer; Doris M Ponce; Esperanza B Papadopoulos; Ian Nykaza; Jad Kanbar; Mario E Lacouture; Michael Scordo; Miguel-Angel Perales; Rizi Ai; Roni Tamari; Stephen Dusza; Tara Maier; Veronica Rotemberg

Sep 17, 2026